[The effect of acebutolol, beta 1-selective blocker, on patients with essential hypertension and asthma]. 1982

M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070 Acebutolol A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action. Acebutolol Hydrochloride,Acetobutolol,Apo-Acebutolol,M & B 17803A,M&B-17803 A,Monitan,Neptal,Novo-Acebutolol,Prent,Rhotral,Sectral,Apo Acebutolol,ApoAcebutolol,M&B 17803 A,M&B17803 A,Novo Acebutolol,NovoAcebutolol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
May 1976, The American journal of medicine,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
January 1998, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
May 2012, Indian journal of pharmacology,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
June 1978, The American journal of medicine,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
January 1997, Terapevticheskii arkhiv,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
January 2002, Kardiologiia,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
March 1978, Die Medizinische Welt,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
November 1989, Arzneimittel-Forschung,
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
October 1998, Clinical and experimental hypertension (New York, N.Y. : 1993),
M Nakashima, and M Kawai, and T Kurasawa, and N Maekawa, and T Kino, and K Mitsuyasu, and S Oshima
August 1997, American journal of hypertension,
Copied contents to your clipboard!